β-Glucans reduce LDL cholesterol in patients with myasthenia gravis

European Journal of Clinical Nutrition

Volumn 67, Issue 2, 2013, Pages 226-227

  Haggard L ^a   Andersson, M ^a   Punga, A R ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

glucans; glycemic control; LDL cholesterol; myasthenia gravis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BETA GLUCAN; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NUTRITIONAL ASSESSMENT; NUTRITIONAL VALUE; PROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; APOLIPOPROTEINS B; BETA-GLUCANS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MYASTHENIA GRAVIS;

EID: 84873480355     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.191     Document Type: Article

References (10)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
2. Delahoy PJ, Magliano DJ, Webb K, Grobler M, Liew D. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: An updated meta-analysis. Clin Ther 2009; 31: 236-244.
3. Oh SJ, Dhall R, Young A, Morgan MB, Lu L, Claussen GC. Statins may aggravate myasthenia gravis. Muscle Nerve 2008; 38: 1101-1107.
4. Wolever TM, Tosh SM, Gibbs AL, Brand-Miller J, Duncan AM, Hart V et al. Physicochemical properties of oat beta-glucan influence its ability to reduce serum LDL cholesterol in humans: A randomized clinical trial. Am J Clin Nutr 2010; 92: 723-732.
5. Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT. Oat bran concentrate bread products improve long-term control of diabetes: A pilot study. J Am Diet Assoc 1996; 96: 1254-1261.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
7. Braaten JT, Wood PJ, Scott FW, Wolynetz MS, Lowe MK, Bradley-White P et al. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994; 48: 465-474.
8. Purvin V, Kawasaki A, Smith KH, Kesler A. Statin-associated myasthenia gravis: Report of 4 cases and review of the literature. Medicine (Baltimore) 2006; 85: 82-85.
9. Robinson JG, Wang S, Jacobson TA. Meta-Analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials. Am J Cardiol 2012; 110: 1468-1476.
10. Granfeldt Y, Nyberg L, Bjorck I. Muesli with 4 g oat beta-glucans lowers glucose and insulin responses after a bread meal in healthy subjects. Eur J Clin Nutr 2008; 62: 600-607.